Peripheral Neuropathy

Condition: Peripheral Neuropathy  |  Category: Neurological Health  |  Reviewed by: Brian Lamkin, DO

What Is Peripheral Neuropathy?

Peripheral neuropathy is damage to the peripheral nerves, the network that transmits sensation, motor signals, and autonomic function between the central nervous system and the rest of the body. It most commonly affects the longest nerves first (length-dependent pattern), producing numbness, tingling, burning, and pain in the feet and hands. As it progresses, it produces balance impairment, muscle weakness, and autonomic dysfunction.

Diabetes is the most commonly identified cause, but the metabolic nerve damage begins at the insulin resistance stage, years before blood sugar meets diabetic diagnostic criteria. A patient with fasting glucose of 95, HbA1c of 5.5, and fasting insulin of 18 does not meet diabetic criteria but has the hyperinsulinemia, oxidative stress, and advanced glycation end products (AGEs) that produce nerve damage. This "prediabetic neuropathy" is the most commonly missed pattern because the neuropathy workup looks for diabetes and finds none, labeling the case idiopathic. Up to 30 percent of "idiopathic" neuropathy has an identifiable metabolic mechanism when fasting insulin and HOMA-IR are measured.

Why Peripheral Neuropathy Matters

Common Symptoms

Root Causes: A Functional Medicine Perspective

Peripheral neuropathy has identifiable mechanisms. "Idiopathic" neuropathy often becomes identifiable when the metabolic evaluation is comprehensive.

Insulin Resistance and Metabolic Neuropathy

Insulin resistance produces nerve damage through multiple mechanisms that operate below the diabetic diagnostic threshold: oxidative stress from reactive oxygen species, advanced glycation end products (AGEs) that damage nerve proteins, impaired vasa nervorum blood flow reducing nerve oxygen delivery, and mitochondrial dysfunction in nerve tissue. Fasting insulin and HOMA-IR identify this mechanism when fasting glucose and HbA1c are still "normal."

B12 and Nutritional Deficiency

B12 is essential for myelin synthesis. Deficiency produces demyelinating neuropathy that begins with paresthesias and progresses to sensory ataxia if untreated. PPI use, metformin, hypochlorhydria, and gut malabsorption all reduce B12 absorption. Functional B12 deficiency (levels 200 to 400 pg/mL) produces neurological symptoms that are missed by labs reporting these levels as normal. B6 excess (from supplement overuse) paradoxically produces neuropathy through pyridoxine toxicity.

Oxidative Stress and Inflammatory Damage

Chronic inflammation produces oxidative stress that damages nerve mitochondria, particularly in the vasa nervorum (the small blood vessels supplying nerves). Oxidative stress depletes glutathione and damages the electron transport chain in nerve cells, producing energy failure and axonal degeneration. Alpha-lipoic acid is the evidence-based intervention for this mechanism.

Medication-Induced Neuropathy

Statins produce mitochondrial dysfunction through CoQ10 depletion that affects nerve tissue. Fluoroquinolone antibiotics produce mitochondrial damage and tendon/nerve toxicity. Chemotherapy agents (taxanes, platinum compounds, vinca alkaloids) directly damage peripheral nerves. Identifying the medication as the cause and discontinuing it when possible halts progression.

Conventional vs Functional Medicine Approach

Key Labs to Evaluate

How to Interpret These Labs Together

Common Patterns Seen in Patients

• The "idiopathic neuropathy" patient with fasting insulin of 22: numbness and tingling in feet for 3 years. NCS normal (small fiber, not detected). Fasting glucose 98 (normal), HbA1c 5.6 (normal). Labeled idiopathic. Fasting insulin 22, HOMA-IR 5.3 (severely insulin resistant). Insulin sensitization with dietary modification plus alpha-lipoic acid 600mg daily reduced fasting insulin to 8 over 6 months. Neuropathy symptoms improved by 60 percent. The "idiopathic" neuropathy had an identifiable and treatable metabolic mechanism.
• The patient on gabapentin 1800mg with no improvement: gabapentin prescribed for burning foot pain. Dose escalated three times with partial sedation but minimal pain improvement. B12 never checked. B12: 245 pg/mL. Methylmalonic acid: elevated (confirming tissue deficiency). PPI for GERD was depleting B12. Methylcobalamin repletion plus PPI taper with GERD root-cause treatment. B12 rose to 680. Burning pain resolved over 4 months. Gabapentin tapered to discontinuation.
• The patient with new neuropathy after starting a statin: progressive tingling in feet starting 4 months after atorvastatin initiation. Attributed to aging. Statin-induced mitochondrial dysfunction through CoQ10 depletion is a documented neuropathy mechanism. Statin risk-benefit reassessed. CoQ10 supplementation (200mg ubiquinol). Neuropathy improved over 3 months after statin discontinuation with continued cardiovascular risk management through alternative strategies.

Treatment and Optimization Strategy

Mechanism-Specific Neuropathy Treatment

What Most Doctors Miss

• Fasting insulin is not measured: the most common modifiable cause of neuropathy is insulin resistance, which produces nerve damage before glucose meets diabetic criteria. Fasting insulin identifies this mechanism when fasting glucose and HbA1c are "normal."
• B12 functional deficiency is missed by standard thresholds: neurological symptoms begin at B12 levels that labs report as normal (below 400 to 500). Every patient on PPIs or metformin should have B12 monitored regularly.
• Small fiber neuropathy is invisible to nerve conduction studies: NCS measures large fiber function. Small fiber neuropathy (the earliest and most common pattern) requires skin punch biopsy or specialized testing for diagnosis.
• Medication-induced neuropathy is attributed to aging: statin and fluoroquinolone neuropathy are documented but frequently attributed to "getting older" without evaluating the medication timeline.

When to Seek Medical Care

If you experience numbness, tingling, burning, or pain in your feet or hands, particularly if it is progressive, you should receive a comprehensive metabolic evaluation including fasting insulin (not just glucose), B12 with methylmalonic acid, and inflammatory markers. If you have been diagnosed with "idiopathic neuropathy" without these tests, a functional medicine evaluation may identify the treatable mechanism that standard workup missed.

Recommended Testing

Frequently Asked Questions

How The Lamkin Clinic Approaches Peripheral Neuropathy

At The Lamkin Clinic, neuropathy evaluation includes fasting insulin and HOMA-IR (not just glucose and HbA1c), B12 with methylmalonic acid (not just B12 alone), hs-CRP, vitamin D, RBC magnesium, and comprehensive medication review. Treatment targets the specific mechanism: insulin sensitization for metabolic neuropathy, B12 repletion for nutritional neuropathy, anti-inflammatory and antioxidant support for inflammatory damage, and medication discontinuation when a drug-induced mechanism is identified.

Related Conditions

Related Symptoms